{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:00:17Z","timestamp":1791082817058,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ijpharm.2009.01.024","type":"journal-article","created":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T09:46:53Z","timestamp":1233827213000},"page":"124-132","source":"Crossref","is-referenced-by-count":90,"title":["Diclofenac nanosuspensions: Influence of preparation procedure and crystal form on drug dissolution behaviour"],"prefix":"10.1016","volume":"373","author":[{"given":"Francesco","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sinico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ennas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marongiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giaime","family":"Marongiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2009.01.024_bib1","series-title":"Pharmaceutics: The Science of Dosage Form Design","author":"Aulton","year":"2002"},{"key":"10.1016\/j.ijpharm.2009.01.024_bib2","first-page":"794","article-title":"Two monoclinic forms of diclofenac acid","volume":"53","author":"Castellani","year":"1997","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib3","volume":"vol. 2","author":"Ferrari","year":"1972"},{"key":"10.1016\/j.ijpharm.2009.01.024_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/A:1025421911670","article-title":"Thermal degradation and melting point determination of diclofenac","volume":"73","author":"Giordano","year":"2003","journal-title":"J. Thermal Anal. Calorim."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(99)00412-3","article-title":"Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide","volume":"196","author":"Jacobs","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib6","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2116\/analsci.17.1465","article-title":"New orthorhombic form of 2-[(2,6 dichlorophenyl)amino]benzeneacetic acid (diclofenac acid)","volume":"17","author":"Jaiboon","year":"2001","journal-title":"Anal. Sci."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","article-title":"Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization","volume":"62","author":"Keck","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing\u2014oral formulation development and biopharmaceutical evaluation","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2006.01.008","article-title":"Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs","volume":"312","author":"Kocbek","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","article-title":"Microemulsion-based media as novel drug delivery systems","volume":"45","author":"Lawrence","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-5173(95)00122-Y","article-title":"Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs","volume":"125","author":"Liversidge","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib12","unstructured":"Martindale-The complete drug reference, 2002. 33rd ed. Sweetman, C.S. (Ed.), Pharmaceutical Press, London, pp. 30\u201332."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib13","series-title":"Particles","article-title":"Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds","author":"Merisko-Liversidge","year":"2002"},{"key":"10.1016\/j.ijpharm.2009.01.024_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0928-0987(02)00251-8","article-title":"Nanosizing: a formulation approach for poorly-water-soluble compounds","volume":"18","author":"Merisko-Liversidge","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejpb.2005.09.005","article-title":"Spray coated pellets as carrier system for mucoadhesive drug nanocrystals","volume":"62","author":"Moschwitzer","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1107\/S0021889804002353","article-title":"Structure determination of diclofenac in a diclofenac-containing chitosan matrix using conventional X-ray powder diffraction data","volume":"37","author":"Muangsin","year":"2004","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib17","unstructured":"Muller, R.H., Becker, R., Kruss, B., Peters, K., 1999. Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution. United States Patent 5,858,410, USA."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future","volume":"47","author":"Muller","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib19","series-title":"Modified-Release Drug Delivery Technology","first-page":"135","author":"Muller","year":"2003"},{"key":"10.1016\/j.ijpharm.2009.01.024_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-409X(00)00096-X","article-title":"Places of emulsions in drug delivery","volume":"45","author":"Nakano","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib21","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2009.01.024_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejpb.2007.02.008","article-title":"A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound","volume":"67","author":"Sigfridsson","year":"2007","journal-title":"Eur. J. Pharm. Biophys."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/A:1012136608249","article-title":"Cyclodextrins: their future in drug formulation and delivery","volume":"14","author":"Stella","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2009.01.024_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-5173(03)00029-2","article-title":"Preparation of griseofulvin nanoparticles from water-dilutable microemulsions","volume":"254","author":"Trotta","year":"2003","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517309000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517309000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T02:21:11Z","timestamp":1545445271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517309000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0378517309000623"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2009.01.024","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}